These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3245296)

  • 21. Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients.
    Celis E; Ou D; Dietzschold B; Koprowski H
    J Virol; 1988 Sep; 62(9):3128-34. PubMed ID: 2457112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody studies on rabies-related viruses.
    King AA
    Onderstepoort J Vet Res; 1993 Dec; 60(4):283-7. PubMed ID: 7777312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic variation of wild and vaccine rabies strains of Egypt.
    Botros BA; Salib AW; Mellick PW; Linn JM; Soliman AK; Scott RM
    J Med Virol; 1988 Feb; 24(2):153-9. PubMed ID: 3351484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New strains of rabies-related viruses isolated from bats in the Ukraine.
    Selimov MA; Smekhov AM; Antonova LA; Shablovskaya EA; King AA; Kulikova LG
    Acta Virol; 1991 May; 35(3):226-31. PubMed ID: 1683127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.
    Montaño-Hirose JA; Lafage M; Weber P; Badrane H; Tordo N; Lafon M
    Vaccine; 1993 Sep; 11(12):1259-66. PubMed ID: 8256507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antigenic relations of the rabies group viruses studied in the blast transformation and immunofluorescence tests].
    Vagabov RM; Barinskiĭ IF; Shubladze AK
    Vopr Virusol; 1979; (3):293-7. PubMed ID: 380163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross protection of mice against different rabies virus isolates.
    Larghi OP; Díaz AM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):268-74. PubMed ID: 2409716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic and molecular characterization of bat rabies virus in Europe.
    Bourhy H; Kissi B; Lafon M; Sacramento D; Tordo N
    J Clin Microbiol; 1992 Sep; 30(9):2419-26. PubMed ID: 1401009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.
    Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic analysis of antigenic variations of street rabies virus: detection by monoclonal antibodies.
    Sureau P; Rollin P; Wiktor TJ
    Am J Epidemiol; 1983 May; 117(5):605-9. PubMed ID: 6342369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
    Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
    Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis.
    Hanlon CA; DeMattos CA; DeMattos CC; Niezgoda M; Hooper DC; Koprowski H; Notkins A; Rupprecht CE
    Vaccine; 2001 Jul; 19(28-29):3834-42. PubMed ID: 11427255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic variants of rabies virus.
    Wiktor TJ; Koprowski H
    J Exp Med; 1980 Jul; 152(1):99-112. PubMed ID: 6156982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human rabies vaccines induce neutralising antibodies against the European bat rabies virus (Duvenhage).
    Lafon M; Herzog M; Sureau P
    Lancet; 1986 Aug; 2(8505):515. PubMed ID: 2875263
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of Mokola virus neutralising antibodies in Nigerian dogs.
    Aghomo HO; Tomori O; Oduye OO; Rupprecht CE
    Res Vet Sci; 1990 Mar; 48(2):264. PubMed ID: 2333438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological evidence of infection of dogs and man in Nigeria by lyssaviruses (family Rhabdoviridae).
    Ogunkoya AB; Beran GW; Umoh JU; Gomwalk NE; Abdulkadir IA
    Trans R Soc Trop Med Hyg; 1990; 84(6):842-5. PubMed ID: 2096520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of rabies-related viruses from Ethiopia.
    Mebatsion T; Cox JH; Conzelmann KK
    Onderstepoort J Vet Res; 1993 Dec; 60(4):289-94. PubMed ID: 7777313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
    Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
    J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.